152 related articles for article (PubMed ID: 7632028)
1. [Hormone replacement therapy in postmenopausal women and cardiovascular risk].
Karam C; Bourmayan C; Desnos M; Guérot C
Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):195-201. PubMed ID: 7632028
[TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
Gaspard UJ
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):671-6. PubMed ID: 8991899
[TBL] [Abstract][Full Text] [Related]
4. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
da Silva PM
Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
[TBL] [Abstract][Full Text] [Related]
5. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].
Stehouwer CD
Ned Tijdschr Geneeskd; 2001 Jan; 145(2):61-4. PubMed ID: 11225257
[TBL] [Abstract][Full Text] [Related]
9. [Hormone replacement therapy and cardiovascular risk in menopausal women].
Simon T; Jaillon P
Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
[TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
Kovacev-Zavisić B; Icin T; Kovacev N
Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
[TBL] [Abstract][Full Text] [Related]
11. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement therapy and cardiovascular pathology in menopause].
Micheli S; Marcucci R; Farsi A; Abbate R
Ann Ital Med Int; 1998; 13(1):37-46. PubMed ID: 9642841
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
14. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
15. Preserving cardiovascular benefits of hormone replacement therapy.
Bush TL
J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone replacement therapy and cardiovascular disease.
Chae CU; Ridker PM; Manson JE
Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
[TBL] [Abstract][Full Text] [Related]
17. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
Motolese M
Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause].
Scarabin PY; Plu-Bureau G
Arch Mal Coeur Vaiss; 1993 Feb; 86(2):243-8. PubMed ID: 8363427
[TBL] [Abstract][Full Text] [Related]
19. [Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases].
Grand A
Ann Cardiol Angeiol (Paris); 1998; 47(7):481-7. PubMed ID: 9772970
[TBL] [Abstract][Full Text] [Related]
20. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
Modena MG; Rossi R; Muia N; Origliani G; Rombolà O; Molinari R
G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
